14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $58.40 $79.59 Thursday, 25th Apr 2024 EXAS stock ended at $58.79. This is 7.04% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 6.97% from a day low at $58.40 to a day high of $62.47.
90 days $56.05 $79.59
52 weeks $56.05 $100.76

Historical EXACT Sciences Corporation prices

Date Open High Low Close Volume
Dec 07, 2020 $133.19 $139.26 $132.21 $134.85 2 552 751
Dec 04, 2020 $131.65 $136.14 $130.13 $132.87 2 347 872
Dec 03, 2020 $123.92 $131.49 $123.92 $130.67 3 292 486
Dec 02, 2020 $123.85 $126.60 $120.50 $124.41 1 946 600
Dec 01, 2020 $122.83 $126.64 $121.38 $123.23 1 569 098
Nov 30, 2020 $119.70 $121.68 $116.87 $121.06 2 201 053
Nov 27, 2020 $117.32 $121.06 $116.00 $118.19 1 065 969
Nov 25, 2020 $117.27 $119.20 $114.11 $115.87 875 310
Nov 24, 2020 $121.25 $121.88 $116.88 $117.26 1 153 007
Nov 23, 2020 $116.80 $120.75 $116.25 $120.54 1 875 203
Nov 20, 2020 $113.93 $116.54 $113.18 $115.23 1 946 931
Nov 19, 2020 $112.89 $115.45 $112.60 $113.18 1 489 353
Nov 18, 2020 $116.75 $117.11 $112.14 $112.36 1 567 814
Nov 17, 2020 $120.17 $121.32 $114.00 $115.64 1 966 202
Nov 16, 2020 $125.49 $125.75 $121.05 $121.47 857 800
Nov 13, 2020 $122.69 $125.82 $122.25 $122.71 752 556
Nov 12, 2020 $123.86 $125.23 $119.75 $122.42 1 057 724
Nov 11, 2020 $120.22 $123.65 $119.38 $123.38 987 763
Nov 10, 2020 $122.74 $123.23 $117.20 $118.78 1 273 424
Nov 09, 2020 $126.20 $126.62 $121.22 $123.16 1 342 635
Nov 06, 2020 $125.62 $126.83 $123.58 $123.97 982 133
Nov 05, 2020 $124.00 $127.68 $124.00 $126.68 1 607 438
Nov 04, 2020 $127.48 $128.46 $122.21 $123.15 1 569 545
Nov 03, 2020 $122.84 $126.71 $119.32 $126.15 1 448 761
Nov 02, 2020 $123.83 $125.24 $117.62 $121.89 2 027 473
Click to get the best stock tips daily for free!

About EXACT Sciences Corporation

EXACT Sciences Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid th... EXAS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT